Where is Achilles headquartered?

Achilles is located in London, england.

Who invested in Achilles?

Achilles has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Achilles?

Achilles closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

achillestx.com

Achilles

Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.

Business Model:

Revenue: $0

Employees: 201-500

Geographic Data

Address: 245 Hammersmith Road

City: London

State: england

Zip: W6 8PW

Country: GB

Financial Info

Stage:

grant

Raised Last:

$4M

Raised Total:

$213M

Social

Twitter

Crunchbase

Metrics

4,740,758Website Global Rank

1,832Website Monthly Traffic

Twitter Followers

Description

Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.

Contact Phone:

Contact Email:

IPO Details

Achilles went public on 3/30/2021 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/30/2021

IPO Valuation:
$731M

Ticker Symbol:
ACHL

IPO Price:
$18/share

Amount Raised:
$176M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
7/2022	Grant	1	$4.1M	Horizon Capital Horizon Capital
10/2016	Series A		$17.5M	Syncona UCL Technology Fund
3/2021	IPO		$175.5M
7/2022	Grant		$4.2M	Horizon Europe
5/2021	Grant	1	$965.2k	Horizon 2020 Horizon 2020
9/2019	Series B		$120M	RA Capital Management Forbion Capital Partners Invus Perceptive Advisors
9/2016	Seed Round		$0	AlbionVC Cancer Research Horizons Sixth Element Capital Syncona Partners LLP The Francis Crick Institute UCLB AlbionVC Cancer Research Horizons Sixth Element Capital Syncona Partners LLP The Francis Crick Institute UCLB
11/2020	Series C		$70M	OrbiMed Boxer Capital, LLC RA Capital Syncona Forbion Capital Partners The Invus Group, LLC Perceptive Advisors, LLC Redmile Group
11/2020	Series C	8	$69.8M	RA Capital Management Redmile Group Invus Boxer Capital OrbiMed Perceptive Advisors Forbion Capital Partners Syncona Partners LLP RA Capital Management Redmile Group Invus Boxer Capital OrbiMed Perceptive Advisors Forbion Capital Partners Syncona Partners LLP
9/2019	Series B	6	$120.9M	RA Capital Management Syncona Partners LLP Redmile Group Perceptive Advisors Invus Forbion Capital Partners RA Capital Management Syncona Partners LLP
9/2016	Seed Round	6	$17.2M

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details